Assesment of the effect of supplemental aqueous extracts of Achillea milefolium in Multiple sclerosis patients
Phase 2
- Conditions
- multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT2013121915863N1
- Lead Sponsor
- Rafsanjan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Inclusion criteria were an age of 16 to 55 years; a diagnosis of multiple sclerosis, according to the revised McDonald criteria; a relapsing–remitting course; one or more documented relapses in the previous year or two or more in the previous 2 years; and a score of 0 to 5.5 on the EDSS. exclusion criteria were relapse or corticosteroid treatment within 30 days before randomization, active infection, or clinically significant systemic disease.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method